EXAGEN INC. Operating Income Loss

• EXAGEN INC. showed a decrease of -3.2% in Operating Income Loss from 2024 to 2025.
• This data is from EXAGEN INC.'s annual report (Form 10-K), filed with the SEC on March 10, 2026.
• XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 8 years of available data (2018 to 2025), EXAGEN INC.'s Operating Income Loss has declined by 188.3%.
• Historical annual values: Fiscal year 2025: -$14.07 million | Fiscal year 2024: -$13.64 million | Fiscal year 2023: -$22.84 million | Fiscal year 2022: -$46.05 million | Fiscal year 2021: -$24.07 million | Fiscal year 2020: -$15.19 million | Fiscal year 2019: -$9.30 million | Fiscal year 2018: -$4.88 million.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026